Answers are grounded in this paper and cite their sources.
Collagen peptides exhibit diverse bioactivities, but their anti‐photoaging sequences and targets remain unclear. Here, an anti‐photoaging collagen peptide, LGPL, was identified. Pull‐down and surface plasmon resonance (SPR) assays identified RPN2 as its interacting target in HaCaT cells. Peptidomic analysis with in silico screening confirmed LGPL. In UVB‐irradiated HaCaT cells, LGPL (3 mg/mL) significantly enhanced migration. Compared with the UVB group, LGPL reduced reactive oxygen species (ROS) and malondialdehyde (MDA) by 85% and 45%, increased Type I collagen by 49%, and reduced MMP1 and MMP9 by 10%. Pull‐down and SPR analyses showed binding to RPN2 with a dissociation constant ( K D ) of 14.2 µM and a binding energy of −8.6 kcal/mol. The stable LGPL–RPN2 complex alleviated UVB‐induced damage by promoting cell proliferation, suppressing ROS, MDA, and MMPs, and enhancing Type I collagen synthesis, providing mechanistic insight and targets for peptide‐based anti‐photoaging interventions.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: